VTGN
Price
$2.73
Change
-$0.09 (-3.19%)
Updated
Nov 14 closing price
XLO
Price
$0.96
Change
-$0.04 (-4.00%)
Updated
Nov 14 closing price
103 days until earnings call
Ad is loading...

VTGN vs XLO

Header iconVTGN vs XLO Comparison
Open Charts VTGN vs XLOBanner chart's image
VistaGen Therapeutics
Price$2.73
Change-$0.09 (-3.19%)
Volume$490.8K
CapitalizationN/A
Xilio Therapeutics
Price$0.96
Change-$0.04 (-4.00%)
Volume$125.04K
CapitalizationN/A
VTGN vs XLO Comparison Chart
Loading...
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
VTGN vs. XLO commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VTGN is a Hold and XLO is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (VTGN: $2.73 vs. XLO: $0.96)
Brand notoriety: VTGN and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VTGN: 247% vs. XLO: 44%
Market capitalization -- VTGN: $76.01M vs. XLO: $42.08M
VTGN [@Biotechnology] is valued at $76.01M. XLO’s [@Biotechnology] market capitalization is $42.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VTGN’s FA Score shows that 0 FA rating(s) are green whileXLO’s FA Score has 1 green FA rating(s).

  • VTGN’s FA Score: 0 green, 5 red.
  • XLO’s FA Score: 1 green, 4 red.
According to our system of comparison, XLO is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VTGN’s TA Score shows that 4 TA indicator(s) are bullish while XLO’s TA Score has 4 bullish TA indicator(s).

  • VTGN’s TA Score: 4 bullish, 6 bearish.
  • XLO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, XLO is a better buy in the short-term than VTGN.

Price Growth

VTGN (@Biotechnology) experienced а -12.50% price change this week, while XLO (@Biotechnology) price change was -7.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

VTGN is expected to report earnings on Aug 10, 2023.

XLO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($76M) has a higher market cap than XLO($42.1M). XLO YTD gains are higher at: 74.055 vs. VTGN (-46.887).
VTGNXLOVTGN / XLO
Capitalization76M42.1M181%
EBITDAN/AN/A-
Gain YTD-46.88774.055-63%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash13.4KN/A-
Total Debt2.12MN/A-
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VTGNXLO
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
0%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with NTLA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.19%
NTLA - VTGN
43%
Loosely correlated
-6.15%
KYMR - VTGN
43%
Loosely correlated
-5.52%
BEAM - VTGN
41%
Loosely correlated
-4.33%
IOVA - VTGN
41%
Loosely correlated
-4.56%
ALT - VTGN
41%
Loosely correlated
-11.19%
More

XLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XLO has been loosely correlated with AVTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if XLO jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-4.04%
AVTX - XLO
36%
Loosely correlated
+0.60%
TPIA - XLO
25%
Poorly correlated
N/A
VTGN - XLO
23%
Poorly correlated
-3.19%
MTNB - XLO
23%
Poorly correlated
-10.65%
COYA - XLO
23%
Poorly correlated
-5.94%
More